Tranexamic Acid Use in a Patient with a Life-threatening Bleed Exacerbated by Coagulopathy Due to an Aortic Aneurysm with an Endoleak: A Case Report

Tranexamic acid (TXA) is an anti-fibrinolytic agent that inhibits plasminogen activation by binding to its lysine receptor sites and preventing its conversion to plasmin. It stabilizes clots to reduce bleeding and has been used in the setting of trauma, heavy menstrual bleeding, and hematologic mali...

Descripción completa

Detalles Bibliográficos
Autores principales: Werbin, Ashley, Fong, Allen, Shahin, George, Henderson, Aaron, Surry, Luke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Cardiac/Thoracic/Vascular Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713243/
https://www.ncbi.nlm.nih.gov/pubmed/31489276
http://dx.doi.org/10.7759/cureus.5486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713243/
https://www.ncbi.nlm.nih.gov/pubmed/31489276
http://dx.doi.org/10.7759/cureus.5486

Ejemplares similares